Owlet (OWLTW) Operating Leases (2022 - 2023)
Owlet (OWLTW) reported Operating Leases of $22000.0 for Q4 2023, down 98.11% year-over-year from $1.2 million in Q4 2022, and down 69.44% on a QoQ basis from $72000.0 in Q3 2023.
Owlet (OWLTW) has 2 years of Operating Leases data on file, last reported at $22000.0 in Q4 2023.
- Quarterly Operating Leases fell 98.11% year-over-year to $22000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $22000.0 (down 98.11% YoY) and the FY2023 annual result came in at $22000.0, down 98.11% from the prior year.
- Operating Leases slipped to $22000.0 in Q4 2023 per OWLTW's latest filing, from $72000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $3.4 million in Q1 2022 and bottomed at $22000.0 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Owlet | - | - | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 22,000.00 |
| Sep 30, 2023 | 72,000.00 |
| Jun 30, 2023 | 265,000.00 |
| Mar 31, 2023 | 715,000.00 |
| Dec 31, 2022 | 1.16 Mn |
| Sep 30, 2022 | 3.22 Mn |
| Jun 30, 2022 | 2.11 Mn |
| Mar 31, 2022 | 3.44 Mn |